Conceptualizing a model: A report of the ISPOR-SMDM modeling good research practices task force-2

Value in Health

Volumn 15, Issue 6, 2012, Pages 804-811

  Roberts, Mark ^a   Russell, Louise B ^b   Paltiel, A David ^c   Chambers, Michael ^d   McEwan, Phil ^e   Krahn, Murray ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e HEALTH ECONOMICS AND OUTCOMES RESEARCH LTD   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

best practices; conceptualization; methods; modeling

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; CONCEPTUAL FRAMEWORK; GLOMERULUS FILTRATION RATE; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH INSURANCE; HEART INFARCTION; HEPATITIS B; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORTALITY; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RESOURCE ALLOCATION;

ADVISORY COMMITTEES; COMPARATIVE EFFECTIVENESS RESEARCH; CONCEPT FORMATION; CONSENSUS; DECISION SUPPORT SYSTEMS, CLINICAL; EVIDENCE-BASED PRACTICE; MODELS, THEORETICAL;

EID: 84866347343     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.06.016     Document Type: Article

References (63)

1. J.J. Caro, A.H. Briggs, U. Siebert Modeling good research practices - overview: a report of the ISPOR-SMDM modeling good research practices task force-1 Value Health 15 2012 796 803
2. U. Siebert, O. Alagoz, A.M. Bayoumi State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3 Value Health 15 2012 812 820
3. J. Karnon, J. Stahl, A. Brennan Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4 Value Health 15 2012 821 827
4. R. Pitman, D. Fisman, G.S. Zaric Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5 Value Health 15 2012 828 834
5. A.H. Briggs, M. Weinstein, E. Fenwick Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6 Value Health 15 2012 835 842
6. D.M. Eddy, W. Hollingworth, J.J. Caro Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7 Value Health 15 2012 843 850
7. J.S. Mandelblatt, K.A. Cronin, S. Bailey Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms Ann Intern Med 151 2009 738 747
8. H.C. Wijeysundera, M. Machado, X. Wang Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada Value Health 13 2010 915 921
9. S.M. Shechter, C.L. Bryce, O. Alagoz A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process Med Decis Making 25 2005 199 209
10. B. Sander, C.T. Bauch, D. Fisman Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience Vaccine 28 2010 10 20
11. Medical Advisory Secretariat Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis Ont Health Technol Assess Ser [Internet] 10 23 2010 December 1 57 http://www.health.gov.on.ca/ english/providers/program/ mas/tech/reviews/pdf/gep-20101213.pdf [Accessed June 24, 2012]
12. S. Ramwadhdoebe, E. Buskens, R.J. Sakkers, J.E. Stahl A tutorial on discrete-event simulation for health policy design and decision making: optimizing pediatric ultrasound screening for hip dysplasia as an illustration Health Policy 93 2009 143 150
13. Z. Philips, L. Bojke, M. Sculpher, K. Claxton, S. Golder Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment Pharmacoeconomics 24 2006 355 371
14. Z. Philips, L. Ginnelly, M. Sculpher Review of guidelines for good practice in decision-analytic modelling in health technology assessment Health Technol Assess 8 2004 1 158
15. G.W. Torrance, J.E. Siegel, B.R. Luce Framing and designing the cost-effectiveness analysis M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
16. Health Models [Online]. [cited 2011 Feb 6 http://www.statcan.gc.ca/ microsimulation /health-sante/health-sante-eng.htm#a2 [Accessed June 24, 2012]
17. F.S. Erenay, O. Alagoz, R. Banerjee, R.R. Cima Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation Med Decis Making 31 2011 611 624
18. M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein Cost Effectiveness Analysis in Health and Medicine 1996 Oxford University Press New York
19. P.J. Neumann Costing and perspective in published cost-effectiveness analysis Med Care 47 Suppl. 2009 S28 S32
20. E.G. Knox Strategy for rubella vaccination Int J Epidemiol 9 1980 13 23
21. S.Y. Kim, S.J. Goldie Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches Pharmacoeconomics 26 2008 191 215
22. A.E. Kelly, A.C. Haddix, K.S. Scanlon Cost-effectiveness of strategies to prevent neural tube defects Appendix B M.R. Gold, J.E. Siegel, L.B. Russell, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
23. C.M. Rutter, A.M. Zaslavsky, E.J. Feuer Dynamic microsimulation models for health outcomes: a review Med Decis Making 31 2011 10 18
24. M.D. Smith, M. Drummond, D. Brixner Moving the QALY forward: rationale for change Value Health 12 Suppl. 2009 S1 S4
25. M.C. Weinstein, G. Torrance, A. McGuire QALYs: the basics Value Health 12 Suppl. 2009 S5 S9
26. D. Kahneman A different approach to health state valuation Value Health 12 Suppl. 2009 S16 S17
27. J.M. Eisenberg Clinical economics: a guide to the economic analysis of clinical practices JAMA 262 1989 79 86
28. S. Ramsey, R. Willke, A. Briggs Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report Value Health 8 2005 521 533
29. Canadian Agency for Drugs and Technologies in Health Guidelines for the economic evaluation of health technologies: Canada [Internet] 3rd ed. 2006 Canadian Agency for Drugs and Technologies in Health Ottawa vii, 46, A-17 http://www.cadth.ca/media/pdf/ 186-EconomicGuidelines-e.pdf Accessed June 24, 2012
30. D. Henry Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals Pharmacoeconomics 1 1992 54 67
31. M.C. Weinstein, P.G. Coxson, L.W. Williams Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model Am J Pub Health 77 1987 1417 1426
32. G. Chapman, F. Sonnenberg Decision Making in Health Care: Theory, Psychology, and Applications 2003 Cambridge University Press Cambridge
33. D.B. Matchar, G.P. Samsa, J.R. Matthews The Stroke Prevention Policy Model: linking evidence and clinical decisions Ann Intern Med 127 1997 704 711
34. C. Baker, M. Johnsrud, M. Crismon Quantitative analysis of sponsorship bias in economic studies of antidepressants Br J Psychiatry 183 2003 498 506
35. C. Bell, D. Urbach, J. Ray Bias in published cost effectiveness studies: systematic review BMJ 332 2006 699 703
36. D. Chauhan, A.H. Miners, A.J. Fischer Exploration of the difference in results of economic submissions to the National Institute of Clinical Excellence by manufacturers and assessment groups Int J Technol Assess Health Care 23 2007 96 100
37. M. Barbieri, M. Drummond Conflict of interest in industry-sponsored economic evaluations: real or imagined? Curr Oncol Rep 3 2001 410 413
38. J. Strzalko, J. Grabski, A. Stefanski Understanding coin-tossing Mathematical Intelligencer 32 2010 54 58
39. A.S. Detsky, G. Naglie, M.D. Krahn Primer on medical decision analysis, Part 1 - getting started Med Decis Making 17 1997 123 125
40. M. Helfand Influence diagrams: a new dimension for decision models Med Decis Making 17 1997 351 352
41. R.F. Nease Jr, D.K. Owens Use of influence diagrams to structure medical decisions Med Decis Making 17 1997 263 275
42. D.K. Owens, R.D. Shachter, R.F. Nease Jr Representation and analysis of medical decision problems with influence diagrams Med Decis Making 17 1997 241 262
43. J.D. Novak, A.J. Carnas Florida Institute for Human and Machine Cognition [Online] 2008 [cited 2011 12 26 http://cmaihmc.us/Publications/ResearchPapers/ TheoryCmaps/TheoryUnderlyingConceptMaps.htm Accessed June 24, 2012
44. M.A. Ruiz-Primo, R.J. Shavelson Problems and issues in the use of concept maps in science assessment J Res Sci Teaching 33 1996 569 600
45. J.E. Stahl Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide Pharmacoeconomics 26 2008 131 148
46. P. Barton, S. Bryan, S. Robinson Modelling in the economic evaluation of health care: selecting the appropriate approach J Health Serv Res Policy 9 2004 110 118
47. K.A. Freedberg, J.A. Scharfstein, G.R. Seage The cost-effectiveness of preventing AIDS-related opportunistic infections JAMA 279 1998 130 136
48. E.F. Long, M.L. Brandeau, D.K. Owens Potential population health outcomes and expenditures of HIV vaccination strategies in the United States Vaccine 27 2009 5402 5410
49. A. Richter, B. Loomis Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model Health Care Manag Sci 8 2005 67 79
50. W.D. Leslie, R.C. Brunham The dynamics of HIV spread: a computer simulation model Comput Biomed Res 23 1990 380 401
51. T.C. Porco, P.M. Small, S.M. Blower Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks J Acquir Immune Defic Syndr 28 2001 437 444
52. A. Auchincloss, A. Diez Roux A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health Am J Epidemiol 168 2008 1 8
53. B.P. Linas, E. Losina, A. Rockwell Improving outcomes in state AIDS drug assistance programs J Acquir Immune Defic Syndr 51 2009 513 521
54. G.S. Zaric, P.G. Barnett, M.L. Brandeau HIV transmission and the cost-effectiveness of methadone maintenance Am J Public Health 90 2000 1100 1111
55. A.S. Detsky, G. Naglie, M.D. Krahn Primer on medical decision analysis, part 2 - building a tree Med Decis Making 17 1997 126 135
56. K. Carlson, A. Mulley Management of acute dysuria: a decision-analysis model of alternative strategies Ann Intern Med 102 1985 244 249
57. H.M. Krumholz, R.C. Pasternak, M.C. Weinstein Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction N Engl J Med 327 1992 7 13
58. G. Clermont, J. Bartels, R. Kumar In silico design of clinical trials: a method coming of age Crit Care Med 32 2004 2061 2070
59. S. Daun, J. Rubin, Y. Vodovotz, G. Clermont Equation-based models of dynamic biological systems J Crit Care 23 2008 585 594
60. R. Kumar, C.C. Chow, J.D. Bartels A mathematical simulation of the inflammatory response to anthrax infection Shock 29 2008 104 111
61. D.M. Eddy, L. Schlessinger Validation of the Archimedes diabetes model Diabetes Care 26 2003 3102 3110
62. L. Schlessinger, D.M. Eddy Archimedes: a new model for simulating health care systems-the mathematical formulation J Biomed Inform 35 2002 37 50
63. Quote Investigator [Online]. [cited 2011 12 27 http://quoteinvestigator. com/2011/ 05/13/einstein-simple Accessed June 24, 2012